Out-of-Stock – COVID-19 – Authorisations for the temporary import and distribution of human medicines – Update

Link permanente della pagina
www.swissmedic.ch/out-of-stock-covid19-en

Status as of 14.04.2021

In Ordinance 3 on Measures to Combat the Coronavirus (Covid-19 Ordinance 3, SR 818.101.24), the Federal Council issues provisions designed to ensure the supply of important medical goods. Based on Art. 22 para. 3 of this ordinance, Swissmedic can approve the import of essentially identical medicinal products as a short-term solution for any temporary non-availability of medicinal products.

Medicinal products imported by hospital pharmacists under their own responsibility according to Art. 22 para. 1 of the Covid-19 Ordinance 3 are not included in this list.

The following table lists the temporary import and distribution licences granted by Swissmedic on the basis of the Covid-19 Ordinance. The goods are usually allocated and information provided on their respective availability by the department at the Federal Office of Public Health responsible for procuring medical goods.

Distribution period ongoing

Active substance Pharmaceutical form / Dosage Batch reference Distribution licensed until
Propofol Emulsion for injection K20001A
K20005A
K20005B
31.12.2022
Remifentanil Powder for preparation of a solution for infusion, 5 mg 50PEH013 30.04.2022
Remifentanil Powder for preparation of a solution for infusion, 1 mg 50PDH010 30.04.2022
Propofol Emulsion for infusion 2 % MCT 16PD7549 31.12.2021
Propofol 20 mg/ml (50 ml emulsion for injection in a pre-filled syringe) RM659 31.12.2021
Sufentanil / Sufentanil citrate Solution for injection, 0.005mg/ml
(10x10 ml)
KY3H
R49N
31.12.2021
Sufentanil / Sufentanil citrate Solution for injection, 0.05mg/ml
(10x5 ml)
9D7B 31.12.2021
Remdesivir Powder for preparation of a solution for infusion, 100 mg C2000141D2
20410871D1
00009D
00009D4
00010D2
20411011M
AP0083BM1
AP0425BM1
25.11.2022
Sufentanil / Sufentanil citrate   Solution for injection,
0.005mg/ml
(5 x 2 ml)
MU9A 29.10.2021
Sufentanil / Sufentanil citrate Solution for injection,
0.005mg/ml
(10 x 10 ml)
JG9W 29.10.2021
Sufentanil / Sufentanil citrate Solution for injection,
0.05 mg/ml
(10 x 5 ml)
HG2B 29.10.2021
Sufentanil / Sufentanil citrate Solution for injection,
0.005 mg/ml
(5 x 10 ml)
BG4B 29.10.2021
Propofol Emulsion for injection/infusion, 10 mg/ml 20K001A
20K001B
20K002A
20K002B
20K003A
20K003B
31.08.2021

Haemagglutininum influenzae A (H1N1) (H3N2)

Haemagglutininum influenzae B (Victoria) (Yamagata)

Suspension for injection X47 30.06.2021
Voriconazol Powder for preparation of a solution for infusion, 200 mg 6452099 30.06.2021
Dexamethasone Tablets, 4 mg 285120C 30.06.2021

Haemagglutininum influenzae A (H1N1)

Haemagglutininum influenzae A (H3N2)

Haemagglutininum influenzae B

Suspension for injection 7132B1A 30.04.2021

Distribution period elapsed: products may still be present at the dispensing outlets; dispensing and use permitted until the batches have expired

Active substance Pharmaceutical form / Dosage Batch reference Distribution licensed until
Rocuronium Solution for injection 50 mg/5 ml T012764 31.01.2021
Hydroxychloroquine Lactab, 200mg IYZ019 001- IYZ019 007 31.12.2020
Propofol Emulsion for injection/infusion, 10 mg/ml V19A013A
V19A013B
V19A013C
31.12.2020
Lopinavir / Ritonavir Film-coated tablets, 200 mg/tab. and 50 mg/tab. 1125683
1125601
1126558
31.12.2020
Lopinavir / Ritonavir Syrup, 400 mg/5 ml and 100 mg/5 ml 6088208
6088549
31.12.2020
Rocuronium Solution for injection 50 mg/5 ml T007003 31.12.2020
Propofol Emulsion for injection and infusion, 10 mg/ml 10PC9969
16PB6740
31.12.2020
Hydroxychloroquine Film-coated tablets, 200 mg JM2447 31.12.2020
Lopinavir / Ritonavir Tablets, 200 mg/50 mg E200320 31.12.2020
Midazolam Ampoules, 50 mg/10 ml F1038F08
F1048F02
31.12.2020
Midazolam Ampoules, 50 mg/10 ml F1058F02 31.12.2020
Atazanavir Capsules, 200 mg ABH6626 30.11.2020
Amoxicillin / Clavulanic acid 2g/200 mg, powder for preparation of a solution for injection or infusion KS3429 30.11.2020
Posaconazole Gastro-resistant tablet, 100 mg T001796
T001390
01.11.2020
Amoxicillin / Clavulanic acid 2g/200 mg, powder for preparation of a solution for injection or infusion KS3426
KS3427
30.10.2020
Amoxicillin / Clavulanic acid 2g/200 mg, powder for preparation of a solution for injection or infusion KP0957 31.08.2020
Budesonide / Formoterol Powder for inhalation, 100 µg/6 µg LATU 31.08.2020
Budesonide / Formoterol Powder for inhalation, 100 µg/6 µg SLGV 31.08.2020
Erythromycin Powder for solution for infusion, 1 g 01124TB23 31.07.2020
Solution for haemodialysis and haemofiltration Sodium 140 mmol/l
Potassium 4 mmol/l
Magnesium 0.75 mmol/l
Chloride 122 mmol/l
Hydrogen phosphate 1 mmol/l
Hydrogen carbonate 22 mmol/l
/ 1000 ml
19G0415
19K0610
30.06.2020